Compared to healthy controls, NK cells in CLL patients demonstrate reduced frequency in the blood and lymph nodes [14], decreased degranulation [47], cytotoxicity [48] and ADCC [49], downregulation of activating receptors [48] and increased CLL surface expression of HLA-E [15, 18]. Here, HLA-E is linked to B-cell chronic lymphocytic leukemia.